title: Plasma von Willebrand factor changes during various reproductive cycle stages in mixed-breed dogs with normal von Willebrand factor and in Doberman pinschers with type-I von Willebrand's disease.
abstract: OBJECTIVE
  To determine whether plasma von Willebrand factor (vWf) concentration changes during the estrous cycle and pregnancy in Doberman Pinschers with type-I von Willebrand's disease (vWd) and in mixed-breed dogs with normal vWf, and if so, whether alterations in vWf concentration are associated with changes in serum concentrations of reproductive hormones.
  
  
  METHODS
  5 sexually intact female Doberman Pinschers with type-I vWf and 8 sexually intact female mixed-breed dogs with normal vWf.
  
  
  METHODS
  Concentrations of plasma vWf and serum progesterone and estradiol-17 beta were measured during the estrous cycle of nonpregnant dogs and during pregnancy, parturition, and lactation. Serum concentrations of total triiodothyronine, total thyroxin, and free thyroxin were measured during pregnancy, parturition, and lactation.
  
  
  RESULTS
  Von Willebrand factor concentration did not change during the estrous cycle, but during pregnancy, vWf concentration gradually increased. Peak concentrations were obtained at parturition and were 103 and 92% higher in mixed-breed dogs and dogs with type-I vWd, respectively, than were mean prepregnancy (anestrus) values. At parturition, total triiodothyronine concentration decreased from the prepregnancy value. The increase in vWf concentration during pregnancy was positively associated with changes in concentration of estradiol-17 beta and was negatively associated with changes in concentration of progesterone.
  
  
  CONCLUSIONS
  The increase in vWf concentration in pregnant bitches may be associated with changes in concentrations of reproductive hormones. However, the increase in vWf concentration during pregnancy may involve other factors because vWf concentration did not change during the estrous cycle of nonpregnant dogs despite increases in concentrations of estradiol-17 beta and progesterone.
authors.affiliation: Department of Pharmacology/Toxicology, Washington State University, Pullman 99164-6510, USA.
authors.forename: J
authors.initials: J
authors.lastname: Moser
authors.forename: K M
authors.initials: KM
authors.lastname: Meyers
authors.forename: R H
authors.initials: RH
authors.lastname: Russon
authors.forename: J J
authors.initials: JJ
authors.lastname: Reeves
mesh_terms: D000818:Animals; D004283:Dog Diseases; D004285:Dogs; D004971:Estrus / Q000097:blood*; D005260:Female; D007743:Labor, Obstetric / Q000097:blood; D007774:Lactation / Q000097:blood; D049590:Postpartum Period / Q000097:blood; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000662:veterinary*; D011270:Pregnancy, Animal / Q000097:blood*; D013045:Species Specificity; D014842:von Willebrand Diseases / Q000097:blood / Q000235:genetics / Q000662:veterinary*; D014841:von Willebrand Factor / Q000378:metabolism*
chemical_list: D014841:von Willebrand Factor